SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-030442
Filing Date
2021-12-03
Accepted
2021-12-03 16:30:51
Documents
21
Period of Report
2021-12-03
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 34404
2 ex99-1.htm EX-99.1 7704
3 ex99-1_001.jpg GRAPHIC 178926
4 ex99-1_002.jpg GRAPHIC 353688
5 ex99-1_003.jpg GRAPHIC 483613
6 ex99-1_004.jpg GRAPHIC 352416
7 ex99-1_005.jpg GRAPHIC 357709
8 ex99-1_006.jpg GRAPHIC 386210
9 ex99-1_007.jpg GRAPHIC 303386
10 ex99-1_008.jpg GRAPHIC 403686
  Complete submission text file 0001493152-21-030442.txt   4098596

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE mymd-20211203.xsd EX-101.SCH 3013
12 XBRL LABEL FILE mymd-20211203_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE mymd-20211203_pre.xml EX-101.PRE 22351
14 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3610
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 211470438
SIC: 2835 In Vitro & In Vivo Diagnostic Substances